HRTX Filings — Heron Therapeutics, Inc. /de/ - FilingSpy
HRTX
Heron Therapeutics, Inc. /de/
A biotech company that makes drugs for pain after surgery and for nausea and vomiting tied to chemotherapy. Its U.S.-marketed products include ZYNRELEF, a long-acting local anesthetic for postoperative pain, and CINVANTI and SUSTOL, anti-nausea medicines given to chemotherapy patients. Founded in 1983, the company ran for decades as A.P. Pharma before renaming itself Heron Therapeutics in 2014 as part of a fresh strategic direction and a relisting on the Nasdaq.
Select a row to see that insider’s individual transactions. † Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +4.46M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.